Shinemed Pharmaceuticals Private Limited
Founded in 2018 and headquartered in Delhi, India.
2018 | Delhi (India) | Active
Shinemed Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 7 Year, 12 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -59.64%
- Profit Growth -69.59%
- Ebitda 5.48%
- Net Worth 6.93%
- Total Assets 49.21%
About Shinemed Pharmaceuticals
Shinemed Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 February 2018 (Seven years 12 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Kumari Vartika and Prakash Chandra serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24306DL2018PTC329478
- Company No.
329478
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Food And Beverages
Who are the key members and board of directors at Shinemed Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumari Vartika  | Director | 15-Feb-2018 | Current |
| Prakash Chandra | Director | 26-Nov-2018 | Current |
Financial Performance of Shinemed Pharmaceuticals.
Shinemed Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 59.64% decrease. The company also saw a substantial fall in profitability, with a 69.59% decrease in profit. The company's net worth moved up by a moderate rise of 6.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shinemed Pharmaceuticals?
Unlock access to Shinemed Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shinemed Pharmaceuticals?
Unlock and access historical data on people associated with Shinemed Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shinemed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shinemed Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
